Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Xenogen  (Stock symbol: XGEN )

860 Atlantic Avenue
Alameda, CA 94601
Website Company Summary Management Team

Management: David W. Carter (CEO/Chairman);  Michael Sterns (Chief Business Officer);  Anthony Purchio (Chief Scientific Officer);  David R. Boyko (VP Legal Services);  Jason Brady (General Counsel)
Outside board: Douglas J. Kawahara (Anesiva Former Director of Planning & Business Development) Gregory T. Schiffman (Affymetrix CFO) Kevin Hrusovsky (Caliper Life Sciences President/CEO);  Michael F. Bigham (Abingworth Management);  Robert Breckon (MDS Capital);  Christine Cordaro (CMEA Life Sciences);  William A. Halter (Management Consultant);  Chris Jones (J._Walter Thompson);  Raymond J. Whitaker (SmithKline)

Business description: Xenogen Corporation, a leading-edge biotechnology company, provides R&D discovery solutions to the pharmaceutical, biotechnology, and chemical manufacturing industries through offering imaging and transgenic technologies. Xenogen Corporation is the exclusive patent licensee of in vivo biophotonic imaging technology, which measures light emitted from sources within a living mammal. New products and services from Xenogen that utilize this proprietary technology help researchers to visualize biological processes in living mammals, as they happen. This novel approach spans virtually all areas of therapeutic investigation and can expedite the drug discovery and development process, thereby offering pharmaceutical and chemical manufacturers the potential to save both time and money in taking products to market.
Partners include: Cell GenesysChironMerckNovartisOnyx PharmaceuticalsOrganonPfizerRocheSugen;  AstraZeneca Plc;  BauschAndLomb;  Cubist Pharmaceutical;  Millenium Pharmaceuticals;  Netherlands Cancer Institute;  SmithKline;  Taconic

Rounds: 4
Recent fundings: Aug 2005   Jul 2003
Capital raised: 110.0M
Last Round: 18.0M
Ownership: Public  
Stock Symbol: XGEN
VCs include: Abingworth ManagementBrentwood Venture CapitalDelphi VenturesPresidio PartnersSR One LimitedSVB CapitalVersant Ventures;  Harvard Private Capital Holdings;  Lombard Odier;  Partners for Growth
Corporate investors: Chevron Techologies

Last Tweets


Last Mentions

Record updated: Jan 2007
Sector: Medical
Year Founded: 1995
Rounds: 4
Recent fundings: Aug 2005   Jul 2003
Capital raised: 110.0M
Last Round: 18.0M
Ownership: Public  
Stock Symbol: XGEN